SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Vasogen-- VAS on TSE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ddl who wrote (334)8/4/2005 12:06:55 PM
From: Pluvia  Read Replies (1) of 377
 
i doubt vsgn "loaded" their groups, although you'd be foolish to pretend this does not happen. my point is simple; mortailty rate of the control group was higher than norm. i happen to believe VSGN's imt will improve mortality and is a useful treatment for chf; i am impressed with the use of an anti-inflammatory such as vsgn and lvro for use in several diseases.

take home, don't get too giddy about these early results, and don't overlook the potential pitfalls - no measure or identification of "stuff" generated in the 10cc's, likely very tough to increase the vsgn dose.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext